Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kefir powder tested as Weight-Loss aid for kids

NCT ID NCT06500104

First seen Jan 07, 2026

Summary

This study tests whether a daily kefir peptide supplement can help obese children lose weight and improve related health issues like insulin resistance and fatty liver. Sixty children with a BMI above the 95th percentile will take either kefir or a placebo for 12 weeks. The goal is to see if this traditional fermented dairy product can offer a simple, safe way to manage childhood obesity.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • China Medical University Children's Hospital

    Taichung, 404, Taiwan

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

kefir peptide (dietary supplement)

What this could lead to

If it works, this could point toward a simple dietary supplement to help manage obesity and related conditions like insulin resistance and fatty liver in children.

What could go wrong

This is a small, early-stage trial with only 60 participants, so results may not apply broadly. The supplement is not a cure and may have limited effect on weight loss.

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.